|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2010-8-10
|
|
pubmed:abstractText |
The majority of patients with Hodgkin lymphoma (HL) achieve disease remission after primary therapy. To the best of the authors' knowledge, no consensus exists for postremission surveillance imaging.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2010 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3835-42
|
|
pubmed:meshHeading |
pubmed-meshheading:20564135-Adolescent,
pubmed-meshheading:20564135-Adult,
pubmed-meshheading:20564135-Aged,
pubmed-meshheading:20564135-Aged, 80 and over,
pubmed-meshheading:20564135-Female,
pubmed-meshheading:20564135-Fluorodeoxyglucose F18,
pubmed-meshheading:20564135-Hodgkin Disease,
pubmed-meshheading:20564135-Humans,
pubmed-meshheading:20564135-Male,
pubmed-meshheading:20564135-Middle Aged,
pubmed-meshheading:20564135-Neoplasms, Second Primary,
pubmed-meshheading:20564135-Positron-Emission Tomography,
pubmed-meshheading:20564135-Predictive Value of Tests,
pubmed-meshheading:20564135-Recurrence,
pubmed-meshheading:20564135-Remission Induction,
pubmed-meshheading:20564135-Retrospective Studies,
pubmed-meshheading:20564135-Tomography, X-Ray Computed,
pubmed-meshheading:20564135-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
|
|
pubmed:affiliation |
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02114, USA.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
